| mRNA |
BRD-K61166597 |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.05 |
| mRNA |
ML258 |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.05 |
| mRNA |
Gefitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.073 |
0.05 |
| mRNA |
PF-184 |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.05 |
| mRNA |
BRD-K02251932 |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.05 |
| mRNA |
Bax channel blocker |
CTRPv2 |
pan-cancer |
AAC |
0.076 |
0.05 |
| mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.05 |
| mRNA |
simvastatin |
CTRPv2 |
pan-cancer |
AAC |
0.077 |
0.06 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.072 |
0.06 |
| mRNA |
Bexarotene |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.06 |